When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.
When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.
复制标题
DOI:
10.1080/13691058.2016.1164899
复制
发表时间:
2016-09
期刊:
影响因子:
--
通讯作者:
Corneli A
中科院分区:
文献类型:
--
作者:
Namey E;Agot K;Ahmed K;Odhiambo J;Skhosana J;Guest G;Corneli A
Oral pre-exposure prophylaxis (PrEP) using the antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) has been shown to dramatically reduce the risk of HIV acquisition for women at higher risk of infection if taken daily. Understanding when and why women would intentionally stop using an efficacious oral PrEP drug within the context of their “normal” daily lives is essential for delivering effective PrEP risk-reduction counselling. We conducted 60 qualitative interviews with women at higher risk of HIV in Bondo, Kenya, and Pretoria, South Africa, as part of a larger study. Participants charted their sexual contacts over the previous six months, indicated whether they would have taken PrEP if available, and discussed whether and why they would have suspended PrEP use. Nearly all participants said they would have used PrEP in the previous six months; half indicated they would have suspended PrEP use at some point. Participants’ reasons for an extended break from PrEP were related to partnership dynamics (e.g., perceived low risk of a stable partner) and phases of life (e.g., trying to conceive). Life events (e.g., holidays and travel) could prompt shorter breaks in PrEP use. These circumstances may or may not correspond to actual contexts of lower risk, highlighting the importance of tailored PrEP risk-reduction counselling.
登录
查看更多内容
DOI:
10.1097/qad.0b013e32834a9338
发表时间:
2011-09-24
期刊:
AIDS (London, England)
影响因子:
--
作者:
Mugo NR;Heffron R;Donnell D;Wald A;Were EO;Rees H;Celum C;Kiarie JN;Cohen CR;Kayintekore K;Baeten JM;Partners in Prevention HSV/HIV Transmission Study Team
通讯作者:
Partners in Prevention HSV/HIV Transmission Study Team
影响因子:
5.4
作者:
Chimbiri, Agnes M.
通讯作者:
Chimbiri, Agnes M.
影响因子:
120.7
作者:
Mugo, Nelly R.;Hong, Ting;Baeten, Jared M.
通讯作者:
Baeten, Jared M.
影响因子:
11.8
作者:
Seifert, Sharon M.;Glidden, David V.;Anderson, Peter L.
通讯作者:
Anderson, Peter L.
影响因子:
1.5
作者:
Domanska, Catherine A.;Teitelman, Anne M.
通讯作者:
Teitelman, Anne M.